Caffeic acid, a versatile pharmacophore: An overview

Mini-Reviews in Medicinal Chemistry

Volumn 11, Issue 8, 2011, Pages 695-713

  Touaibia, M ^a   Jean Francois J ^a   Doiron, J ^a  

^a UNIVERSITÉ DE MONCTON   (Canada)

Author keywords

Anti inflammatory; Anticancer; Antioxidant; Caffeic acid; Integrase inhibitors; Structure activity relationships

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; 2,2' AZINOBIS(3 ETHYLBENZOTHIAZOLINE 6 SULFONIC ACID); 3,4 DIHYDROXYPHENYLETHANOIC ACID; 8 PHENYLOCTYLCAFFEIC ACID; ACETIC ACID DERIVATIVE; ANTINEOPLASTIC AGENT; AROMATIC AMINE; BENZYLCAFFEIC ACID; CAFFEIC ACID; CAFFEIC ACID DERIVATIVE; CAFFEIC ACID PHENETHYL ESTER; CATECHOL DERIVATIVE; CINNAMYLCAFFEIC ACID; CISPLATIN; COUMARIC ACID; DIHYDROCAFFEIC ACID; DOXORUBICIN; FERULIC ACID; FLUOROURACIL; MATRIX METALLOPROTEINASE INHIBITOR; MENADIONE; METHYLCAFFEIC ACID; ORTHO COUMARIC ACID; PARA COUMARIC ACID; PHENETHYLCAFFEIC ACID; PHENOL DERIVATIVE; PROTOCATECHUIC ACID; PYRROLIDINE DERIVATIVE; TROLOX C; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; CANCER CELL; CANCER CELL CULTURE; CARCINOGENESIS; CELL PROLIFERATION; CELL PROTECTION; CELL TYPE; CYTOTOXICITY; DRUG DESIGN; DRUG INHIBITION; DRUG POTENCY; DRUG SYNTHESIS; ENZYME INHIBITION; FLUORINATION; HUMAN; HYDROPHOBICITY; IC 50; IN VITRO STUDY; LIPID PEROXIDATION; NONHUMAN; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; PHARMACODYNAMICS; PHARMACOPHORE; REVIEW; SCAVENGING SYSTEM; STRUCTURE ACTIVITY RELATION; SUBSTITUTION REACTION; THROMBOCYTE AGGREGATION; TUMOR GROWTH;

EID: 79960464465     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/138955711796268750     Document Type: Review

References (118)

1. Newman, D.J. Natural Products as Sources of New Drugs over the Period 1981-2002. J. Nat. Prod., 2003, 66 (7), 1022-1037.
2. Deshpande, S.S.; Sathe, S.K.; Salunkhe, D.K. Chemistry and safety of plant polyphenols. Adv. Exp. Med. Biol., 1984, 177, 457-495.
3. Harris, P.J.; Hartley, R.D. Detection of bound ferulic acid in cell walls of the gramineae by ultraviolet fluorescent microscopy. Nature, 1976, 259, 508-510.
4. Hartley, R.D.; Morrison, W.H.; Himmelsbach, D. S.; Borneman, N. S. Cross-linking of cell wall phenolics to arabinoxylans in graminaceous plants. Phytochemistry, 1990, 29, 3701-3709.
5. Cuvelier, M.E.; Richard, H.; Berset, C. Comparison of the antioxidant activity of some acid phenols: structure-activity relationship. Biosci., Biotechnol., Biochem., 1992, 56 (2), 324-325.
6. Maillard, M.N.; Soum, M.H.; Boivia, P.; Berset, C. Antioxidant activity of barley and malt: relationship with phenolic content. Lebensm. Wiss. Technol., 1996, 3, 238-244.
7. Friedman, M. Chemistry, biochemistry and dietary role of potato polyphenols A review. J. Agric. Food Chem., 1997, 45, 1523-1540.
8. Michaluart, P.; Masferrer, J.L.; Carothers, A.M.; Subbaramaiah, K.; Zweifel, B.S.; Koboldt, C.; Mestre, J.R.; Grunberger, D.; Sacks, P.G.; Tanabe, T.; Dannenberg, A.J. Inhibitory Effects of Caffeic Acid Phenethyl Ester on the Activity and Expression of Cyclooxygenase-2 in Human Oral Epithelial Cells and in a Rat Model of Inflammation. Cancer Res., 1999, 59, 2347-2352.
9. Liao, H.F.; Chen, Y.Y.; Liu, J.J.; Hsu, M.L.; Shieh, H.J.; Liao, H.J.; Shieh, C.J.; Shiao, M.S.; Chen, Y.J. Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion,and metastasis. J. Agric. Food Chem., 2003, 51, 7907-7912.
10. Baranowski, J.D.; Davidson, P.M.; Nagel, C.W.; Brannen, R.L. Inhibition of Saccharomyces cerevisiae by naturally occurring hydroxy cinnamates. J. Food Sci., 1980, 45, 592-594.
11. Huang, W.Y.; Cai, Y.Z.; Zhang, Y. Natural phenolic compounds from medicinal herbs and dietary plants: potential use for cancer prevention. Nutr. Cancer, 2010, 62 (1), 1-20.
12. Slavin, J.L. Mechanisms for the impact of whole grain foods on cancer risk. J. Am. Coll. Nutr., 2000, 19, 300-307.
13. Fresco, P.; Borges, F.; Marques, M.P.; Diniz, C. The anticancer properties of dietary polyphenols and its relation with apoptosis. Curr. Pharm. Des., 2010, 16 (1), 114-1134.
14. Del Rio, D.; Costa, L.G.; Lean, M.E.; Crozier, A. Polyphenols and health: what compounds are involved? Nutr. Metab. Cardiovasc. Dis., 2010, 20 (1), 1-6.
15. Gomes, C.A.; da Cruz, T.G.; Andrade, J.L.; Milhazes, N.; Borges, F.; Marques, M.P.M. Anticancer activity of phenolic acids of natural or synthetic origin: A structure-activity study. J. Med. Chem., 2003, 46, 5395-5401.
16. Fiuza, S.M.; Gomes, C.; Teixeira, L.J., da Cruz, M.T.G.; Cordeiro, M.N.D.S.; Milhazes, N.; Borgesa, F.; Marquesa, M.P.M. Phenolic acid derivatives with potential anticancer properties-a structure-activity relationship study. Part 1: Methyl, propyl and octyl esters of caffeic and gallic acids. Bioorg. Med. Chem., 2004, 12, 3581-3589.
17. Nam, N.H.; You, Y.J.; Kim, Y.; Hong, D.H.; Kimb, H.M.; Ahna, B.Z. Syntheses of Certain 3-Aryl-2-propenoates and Evaluation of Their Cytotoxicity. Bioorg. Med. Chem. Lett., 2001, 11, 1173-1176.
18. Nam, N.H.; Huong, H.T.T.; Kim, H.M.; Ahn, B.Z. Cytotoxic constituents from Notopterygium incisum. Kor. J. Pharmacogn., 2000, 31, 77-81.
19. Rao, C.V.; Desai, D.; Kaul, B.; Amin, S.; Reddy, B.S. Effects of caffeic acid esters on carcinogen-induced mutagenicity and human colon adenocarcinoma cell growth. Chem. Biol. Interact., 1992, 84, 277-290.
20. Guarini, L.; Su, Z.Z.; Zucker, S.; Lin, J.; Grunberger, D.; Fisher, P.B. Growth inhibition and modulation of antigenic phenotype in human melanoma and glioblastoma multiforme cells by caffeic acid phenethyl ester (CAPE). Cell Mol. Biol., 1992, 38, 513-527.
21. Grunberger, D.; Banerjee, R.; Eisinger, K.; Oltz, E.M.; Efros, L.; Caldwell, M.; Estevez, V.; Nakanishi, K. Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis. Experientia, 1988, 44, 230-232.
22. Su, Z.Z., Grunberger, D., Fisher, P.B. Suppression of adenovirus type 5 EIA-mediated transformation and expression of the transformed phenotype by caffeic acid phenethyl ester (CAPE). Mol. Carcinog., 1991, 4, 231-242.
23. Lee, Y.J.; Liao, P.H.; Chen, W.K.; Yang, C.C. Preferential cytotoxicity of caffeic acid phenethyl ester analogues on oral cancer cells. Cancer Lett., 2000, 153, 51-56.
24. Lee, K.W.; Kang, N.J.; Kim, J.H.; Lee, K.M.; Lee, D.E.; Hur, H.J.; Lee, H.J. Caffeic acid phenethyl ester inhibits invasion and expression of matrix metalloproteinase in SK-Hep1 human hepatocellular carcinoma cells by targeting nuclear factor kappa B. Genes Nutr., 2008, 2, 319-322.
25. Chen, M.J.; Chang, W.H.; Lin, C.C.; Liu, C.Y.; Wang, T.E.; Chu, C.H.; Shih, S.C.; Chen, Y.J. Caffeic acid phenethyl ester induces apoptosis of human pancreatic cancer cells involving caspase and mitochondrial dysfunction. Pancreatology, 2008, 8 (6), 566-576.
26. Chiao, C.; Carothers, A.M.; Grunberger, D.; Solomon, G.; Preston, G.A.; Barrett, J.C. Apoptosis and altered redox state induced by caffeic acid phenethyl ester (CAPE) in transformed rat fibroblast cells. Cancer Res., 1995, 55 (16), 3576-3583.
27. Su, Z.Z.; Lin, J.; Prewett, M.; Goldstein, N.I.; Fisher, P.B. Apoptosis mediates the selective toxicity of caffeic acid phenethyl ester (CAPE) toward oncogenetransformed rat embryo fibroblast cells. Anticancer Res., 1995, 15, 1841-1848.
28. Chen, J.H.; Shao, Y.; Huang, M.T.; Chin, C.K.; Ho, C.T. Inhibitory effect of caffeic acid phenethyl ester on human leukemia HL-60 cells. Cancer Lett., 1996, 108, 211-214.
29. Huang, M.T.; Ma, W.; Yen, P.; Xie, J.G.; Han, J.; Frenkel, K.; Grunberger, D.; Conney, A.H. Inhibitory effects of caffeic acid phenethyl ester (CAPE) on 12-O-tetradecanoylphorborl-13-acetateinduced tumor promotion in mouse skin and the synthesis of DNA, RNA, and protein in HeLa cells. Carcinogenesis, 1996, 17, 761-765.
30. Natarajan, K.; Singh, S.; Burke, T.R.Jr.; Grunberger, D.; Aggarwal, B.B. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kB. Proc. Natl. Acad. Sci. USA, 1996, 93, 9090-9095.
31. Banskota, A.H.; Nagaoka, T.; Sumioka, L.Y.; Tezuka, Y.; Awale, S.; Midorikawa, K.; Matsushige, K.; Kadota, S. Antiproliferative activity of the Netherlands propolis and its active principles in cancer cell lines. J. Ethnopharmacol., 2002, 80, 67-73.
32. Nagaoka, T.; Banskota, A.H.; Tezuka, Y.; Saiki, I.; Kadota, S. Selective Antiproliferative Activity of Caffeic Acid Phenethyl Ester Analogues on Highly Liver-Metastatic Murine Colon 26-L5 Carcinoma Cell Line. Bioorg. Med. Chem., 2002, 10, 3351-3359.
33. Jayaprakasam, B.; Vanisree, M.; Zhang, Y.; Dewitt, D.L.; Nair, M.G. Impact of Alkyl Esters of Caffeic and Ferulic Acids on Tumor Cell Proliferation, Cyclooxygenase Enzyme, and Lipid Peroxidation. J Agri. Food Chem., 2006, 54, 5375-5381.
34. Xia, C.H.; Li, H.B.; Liu, F.; Hua, W.X. Synthesis of trans-caffeate analogues and their bioactivities against HIV-1 integrase and cancer cell lines. Bioorg. Med. Chem. Lett., 2008, 18, 6553-6557.
35. Boudreau, L.H.; Picot, N.; Doiron, J.; Villebonnet, B.; Surette, M.E.; Robichaud, G.A.; Touaibia, M. Caffeoyl and cinnamoyl clusters with anti-inflammatory and anti-cancer effects. Synthesis and structure-activity relationship. New J. Chem., 2009, 33, 1932-1940.
36. Folguera, A.R.; Pendas, A.M.; Sanchez, L.M.; Lopez-Otin, C. Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. J. Dev. Biol., 2004, 48, 411-424.
37. Birkedal-Hansen, H. Proteolytic remodeling of extracellular matrix. Curr. Opin. Cell. Biol., 1995, 7, 728-735.
38. John, A.; Tuszynski, G. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol. Oncol. Res., 2001, 7, 14-23.
39. Itoh, T.; Tanioka, M.; Matsuda, H.; Nishimoto, H.; Yoshioka, T.; Suzuki, R.; Uehira, M. Experimental metastasis is suppressed in MMP-9-deficient mice. Clin. Exp. Metastas., 1999, 17, 177-181.
40. Ahonen, M.; Poukkula, M.; Baker, A.H.; Kashiwagi, M.; Nagase, H.; Eriksson, J.E.; Kahari, V.M. Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors. Oncogene, 2003, 22, 2121-2134.
41. Giannelli, G.; Antonaci, S. Gelatinases and their inhibitors in tumor metastasis: from biological research to medical applications. Histol. Histopathol., 2002, 17, 339-345.
42. Li, Y.L.; Xu, W.F. Design, synthesis, and activity of caffeoyl pyrrolidine derivatives as potential gelatinase inhibitors. Bioorg. Med. Chem., 2004, 12, 5171-5180.
43. Sugiura, M.; Naito, Y.; Yamaura, Y.; Fukaya, C.; Yokohama, K. Inhibitory activities and inhibition specificities of caffeic acid derivatives and related compounds toward 5-lipoxygenase. Chem. Pharm. Bull. 1989, 37, 1039-1043.
44. Michaluart, P.; Masferrer, J.L.; Carothers, A.M.; Subbharamaiah, K.; Zweifel, B.S.; Koboldt, C.; Mestre, J.R.; Grunberger, D.; Sacks, P.G.; Tanabe, T.; Dannenberg, A.J. Inhibitiry effects of caffeic acid phenylethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation. Cancer Res. 1999, 59, 2347-2352.
45. Rajan, P.; Vedernikova, I.; Cos, P.; Berghe, D.V.; Augustyns, K.; Haemers, A. Synthesis and evaluation of caffeic acid amides as antioxydants. Bioorg. Med. Chem. Lett. 2001, 11, 215-217.
46. Son, S; Lewis, B.A.; Free radical scavenging and antioxidative activity of caffeic acid amide and ester analogues: Structureactivity relationship. J. Food Agric. Chem. 2002, 50, 468-472.
47. Tsai, W.J.; Hsieh, H.T.; Chen, C.C.; Kuo, Y.C.; Chen, C.F. Characterization of the anti-platelet effects of (2-S)-5-methoxy-6-methylflavan-7-ol from Draconis Resina. Eur. J. Pharmacol. 1998, 346 (1), 103-110.
48. Hung, C.C.; Tsai, W.J.; Kuo, L.M.Y.; Kuo, Y.H. Evaluation of caffeic acid amide analogues as anti-platelet aggregation and antioxidative agents. Bioorg. Med. Chem. 2005, 13, 1791-1797.
49. Wang, X.; Stavchansky, S.; Bowman, P.D.; Kerwin, S.M. Cytoprotective effect of caffeic acid phenylethyl ester (CAPE) and catechol ring fluorinated CAPE derivatives against menadione-induced oxidative stress in human endothelial cells. Bioorg. Med. Chem. 2006, 14, 4879-4887.
50. Wang, X.; Bowman, P.D.; Kerwin, S.M.; Stavchansky, S. Stability of caffeic acid phenethyl ester and its fluorinated derivative in rat plasma. Biomed. Chromatogr. 2007, 21, 343-350.
51. Silva, F.A.M.; Borges, F.; Guimaraes, C.; Lima, J.L.F.C.; Matos, C.; Reis, S. Phenolic acids and derivatives: Studies on the relationship among structure, radical scavenging activity and physicochemical properties. J. Agric. Food Chem. 2000, 48, 2122-2126.
52. Antolovich, M.; Bedgood Jr, D.R.; Bishop, A.G.; Jardine, D.; Prenzler, P.D.; Robards, K. LC-MS investigation of oxidation products of phenolic antioxidants. J. Agric. Food Chem. 2004, 52, 962-971.
53. Gaspar, A.; Garrido, E.M.; Esteves, M.; Quezada, E.; Milhazes, N.; Garrido, J.; Borges, F. New insights into the antioxidant activity of hydrocinnamic acids: Synthesis and physicochemical characterization of novel halogenated derivatives. Europ. J. Med. Chem. 2009, 44, 2092-2099.
54. Zhang, Z.; Xiao, B.; Chen, Q.; Lian, X.Y. Synthesis and biological evaluation of caffeic acid 3, 4-dihydroxyphenethyl ester. J. Nat. Prod. 2010, 73, 252-254.
55. Jayaprakasam, B.; Vanisree, M.; Zhang, Y.; Dewitt, D.L.; Nair, M.G. Impact of alkyl esters of caffeic acid and ferulic acids on tumor cell proliferation, cyclooxygenase enzyme and lipid peroxidation. J. Agric. Food Chem. 2006, 54, 5375-5381.
56. Dinkova-Kostova, A.T.; Abeygunawardana, C.; Talalay, P. Chemoprotective properties of phenylpropenoids, bis(benzylidene) cycloalkanones and related Michael reaction acceptors: correlation of potencies as phase 2 enzyme inducers and radical scavengers. J. Med. Chem. 1998, 41, 5287-5296.
57. Tazaki, H.; Taguchi, D.; Hayashida, T.; Nabeta, K. Stable isotopelabeling studies on the oxidative coupling of caffeic acid via oquinone. Biosci. Biotechnol. Biochem. 2001, 65 (12), 2613-2621.
58. Saito, S.; Kurakane, S.; Seki, M.; Takai, E.; Kasai, T.; Kawabata, J. Radical scavenging activity of dicaffeoyloxycyclohexanes: Contribution of an intramolecular interaction of two caffeoyl residues. Bioorg. Med. Chem. 2005, 13, 4191-4199.
59. Kwak, S.Y.; Seo, H.S.; Lee, Y.S. Synergistic antioxidative activities of hydroxycinnamoyl-peptides. J. Pept. Sci. 2009, 15, 634-641.
60. Seo, H.S.; Kwak, S.Y.; Le, Y. S. Antioxidative activities of histidine containing caffeic acid-dipeptides. Bioorg. Med. Chem.Lett. 2010, 20, 4266-4272.
61. Qiao, L.; Kozoni, V.; Tsioulias, G.J.; Koutsos, M.I.; Hanif, R.; Shiff, S.J.; Rigas, B. Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo. Biochim. Biophys. Acta 1995, 1258, 215-223.
62. Tsujii, M.; DuBois, R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandinendoperoxide synthase 2. Cell 1995, 83, 493-501.
63. Goodwin, J. S.; Ceuppens J. Regulation of immune response by prostaglandins. J. Clin. Immunol. 1983, 3, 295-314.
64. Bennett, A.; Charlier, E.M.; McDonald, A.M.; Simpson, J. S.; Stamford, I.F.; Zebro, T. Prostaglandins and breast cancer. Lancet 1977, 2, 624-626.
65. Rigas, B.; Goldman, I.S.; Levine, L. Altered eicosanoid levels in human colon cancer, J. Lab. Clin. Med. 1993, 122, 518-523.
66. Bennett, A.; Carroll, M.A.; Stamford, I.F.; Whimster, W.F.; Williams, F. Prostaglandins and human lung carcinomas. Br. J. Cancer 1982, 46, 888-893.
67. Maeda, H.; Akaike, T. Nitric oxide and oxygen radicals in infection, inflammation, and cancer, Biochemistry 1998, 63, 854-865.
68. Wink, D.; Vodovotz, Y.; Laval, J.; Laval, F.; Dewhirst, M.W.; Mitchell, J.B. The multifaceted roles of nitric oxide in cancer. Carcinogenesis 1998, 19, 711-721.
69. Peters-Golden, M.; Henderson, W.R. Jr. Leukotrienes N. Engl. J. Med. 2007, 357 (18), 1841-1854.
70. Santangelo, C.; Vari, R.; Scazzochio, B.; Di Benedetto, R.; Filesi, C.; Masella, R. Polyphenols, intracellular signaling and inflammation. Ann. Ist. Super. Sanita 2007, 43 (4), 394-405.
71. Lee, S.J.; Kim, C.E.; Seo, K.W.; Kim, C.D. HNE-induced 5-LO expression is regulated by NF-B/ERK and Sp1/p38 MAPK pathways via EGF receptor in murine macrophages. Cardiovasc. Res. 2010, 88, 352-359.
72. Chung, T.W.; Moon, S.K.; Chang, Y.C.; Ko, J.H.; Lee, Y.C.; Cho, G.; Kim, S.H.; Kim, J.G.; Kim, C.H. Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepataoma growth and metastasis by dual mechanism. FASEB J. 2004, 18, 1670-1681.
73. Lee, K.W.; Kang, N.J.; Kim, J,H.; Lee, K.M.; Lee, D.E.; Hur, H.J.; Lee, H.J. Caffeic acid phenethyl ester inhibits invasion and expression of matrix metalloproteinase in SK-Hep1 human hepatocellular carcinoma cells by targeting nuclaer factor kappa B. Genes Nutr. 2008, 2, 319-322.
74. Bose, J.S.; Gangan, V.; Jain, S.K.; Manna, S.K. Downregulation of inflammatory responses by novel caffeic acid ester derivative by inhibiting NF-_kB. J. Clin. Immunol. 2009, 29, 90-98.
75. Bose, J.S.; Gangan, V.; Jain, A.K.; Manna, S.K. Novel caffeic acid ester derivative induces apoptosis by expressing FasL and downregulating NF-_kB:Potentiation of cell death mediated by chemotherapeutic agents. J. Cell Physiol. 2009, 218, 653-662.
76. Lechner, M.; Lirk, P.; Rieder, J. Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin. Sem. Cancer Biol. 2005, 15 (4), 277-289.
77. Clancy, R.M.; Amin, A.R.; Abramson, S.B. the role of nitric oxide in inflammation and immunity. Arthritis Rheum. 1998, 41 (7), 1141-1151.
78. Wink, D.A.; Hanbauer, I.; Grisham, M.B.; Laval, F; Nims, R.W.; Laval, J. Chemical biology of nitric oxide: regulation and protective and toxic mechanisms. Curr. Top. Cell. Regul. 1996, 34, 159-187.
79. Stamler. J.S. Redox signalling: nitrosylation and related target interactions of nitric oxide. Cell 1994, 78, 931-936.
80. Nagaoka, T.; Banskota, A.H.; Tezuka, Y.; Midorikawa, K.; Matushige, K.; Kadota, S. Caffeic acid phenyl ethyl (CAPE) ester: potent nitric oxide inhibitors from the Netherlands propolis. Biol. Pharm. Bull. 2003, 26, 487-491.
81. Uwai, K.; Osanai, Y.; Imaizumi, T.; Kanno, S; Takeshita, M.; Ishikawa, M. Inhibitory effect of the alkyl side chain of caffeic acids analogues on lipopolysaccharide-induced nitric oxide production un RAW264.7 macrophages. Bioorg. Med. Chem. 2008, 16, 7795-7803.
82. Hsiao, G.; Shen, M.Y.; Chang, W.C.; Cheng, Y.W.; Pan, A.L.; Kuo, Y.S.; Chen, T.F.; Sheu, J.R. A novel antioxidant, octyl caffeate, suppression of LPS/IFN-γ-induced inducible nitric oxide synthase gene expression in rat aortic smooth muscle cells. Biochem. Pharmacol. 2003, 65, 1383-1392.
83. De Lucia, M.; Panzella, L.; Crescenzi, O.; Napolitano, A.; Barone, V.; d'Ischia, M. The catecholic antioxidant piceatannol is an effective nitrosation inhibitor via an unusual double bond nitration. Bioorg. Med. Chem. Lett. 2006, 16, 2238-2242.
84. De Lucia, M.; Panzella, M.; Pezzella, A.; Napolitano, A.; d'Ischia, M. Plant catechols and theirs glutathionyl conjugates as antinitrosating agents: Expedient synthesis and remarkable potency of 5-S-glutathionylpiceatannol. Chem. Res. Toxicol. 2008, 21, 2407-2413.
85. Spanbroek, R.; Habenicht, A.J. The Potential role of antileukotriene drugs in atherosclerosis, Drug News Perspect., 2003, 16, 485-489.
86. Helgadottir, A.; Manolescu, A.; Thorleifsson, G.; Gretarsdottir, S.; Jonsdottir, H.; Thorsteinsdottir, U.; Samani, N.J.; Gudmundsson, G.; Grant, S.F.; Thorgeirsson, G.; Sveinbjornsdottir, S.; Valdimarsson, E.M.; Matthiasson, S.E.; Johannsson, H.; Gudmundsdottir, O.; Gurney, M.E.; Sainz, J.; Thorhallsdottir, M.; Andresdottir, M.; Frigge, M.L.; Topol, E.J.; Kong, A.; Gudnason, V.; Hakonarson, H.; Gulcher, J.R.; Stefansson, K. The gene encoding 5- lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat. Genet. 2004, 36, 233-239.
87. Maycock, A.L.; Pong, S.S.; Evans, J.F.; Miller, D.K. Biochemistry of the lipoxygenase pathways. In Leukotrienes and Lipoxygenases; Rokach, J., Ed.; Elsevier Science: New York, 1989; pp 143-208.
88. Pergola, C.; Werz, O. 5-Lipoxygenase inhibitors: a review of recent developments and patents. Expert Opin. Therap. Pat., 2010, 20 (3), 355-375.
89. Mirzoeva, O.K.; Calder, P.C.; The effect of propolis and its components on eicosanoid production during the inflammatory response. Prostaglandins Leukot. Essent. Fatty Acids, 1996, 55 (6), 441-449.
90. Sud'ina, G.F.; Mirzoeva, O.K.; Pushkareva, M.A.; Korshunova, G.A.; Sumbatyan, N.V.; Varfolomeev, S.D. Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Lett., 1993, 329, 21-24.
91. Nordberg, J.; Arner, E.S. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med., 2001, 31, 1287-1312.
92. Schewe T. Molecular actions of ebselen an antiinflammatory antioxidant. Gen. Pharmacol., 1995, 26, 1153-1161.
93. Lin, C.F.; Chang, T.C.; Chiang, C.C.; Tsai, H.J.; Hsu, L.Y. Synthesis of Selenium-Containing Polyphenolic Acid Esters and Evaluation of Their Effects on Antioxidation and 5-Lipoxygenase Inhibition. Chem. Pharm. Bull., 2005, 53 (11) 1402-1407.
94. Doiron, J.; Boudreau, L.H.; Picot, N.; Villebonet, B.; Surette, M.E.; Touaibia, M. Synthesis and 5-lipoxygenase inhibitory activity of new cinnamoyl and caffeoylclusters. Bioorg. Med. Chem. Lett., 2009, 19, 1118-1121.
95. Mammen, M.; Choi, S.-K.; Whitesides, G.M. Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors. Angew. Chem. Int. Ed., 1998, 37 (20), 2755-2794.
96. Carter, G.W.; Young, P.R.; Albert, D.H.; Bouska, J.; Dyer, R.; Bell, R.L.; Summers, J.B.; Brooks, D.W. 5-Lipoxygenase inhibitory activity of zileuton. J. Pharmacol. Exp. Ther. 1991, 256, 929-937.
97. Note: a library of ~50 caffeic acid derivaitives revealed several good inhibitors Touaibia et al., manuscript in preparation.
98. De Clercq, E. Toward improved anti-HIV chemotherapy: Therapeutic strategies for intervention with HIV infections. J. Med. Chem., 1995, 38, 2491-2517.
99. LaFemina, R.L.; Schneider, C.L.; Robbins, H.L.; Callahan, P.L.; LeGrow, K.; Roth, E.; Schleif, W.A.; Emini, E.A. Requirement of active human immunodeficiency virus type 1 integrase for productive infection of human T-lymphoid cells. J. Virol., 1992, 66(12), 7414-7419.
100. Sakai, H.; Kawamura, M.; Sakuragi, J.; Sakuragi, S.; Shibata, R.; Ishimoto, A.; Ono, H.; Ueda, S.; Adachi, A. Integration is essential for efficient gene expression of human immunodeficiency virus type 1. J. Virol., 1993, 7, 1169-1174.
101. Taddeo, B.; Haseltine, W.A.; Farnet, C.M. Integrase mutants of human immunodeficiency virus type 1 with a specific defect in integration. J. Virol., 1994, 68, 8401-8405.
102. Engelman, A.; Englund, G.; Orenstein, J.M.; Martin, M.A.; Craigie, R. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J. Virol., 1995, 69, 2729-2736.
103. Raffanti, S.; Hass, D.W. In Goodman and Gilman's: The Pharmacological Basis of Therapeutics; Hardman, Limbird, Gilman, Eds.; 10th ed. McGraw-Hill, NewYork, 2001, pp. 1351-1380.
104. Burke, T.R.Jr.; Fesen, M.R.; Mazumder, A.; Wang, J.; Carothers, A.M.; Grunberger, D.; Driscoll, J.; Kahn, K.; Pommier, Y. Hydroxylated aromatic inhibitors of HIV-1 integrase. J. Med. Chem., 1995, 38, 4171-4178.
105. Ho, C.C.; Lun, S.S.; Chou, M.Y.; Chen, F.L.; Hu, C.C.; Chen, C.S.; Lu, G.Y, Yang, C.C. Effects of CAPE-like compounds on HIV replication in vitro and modulation of cytokines in vivo. J. Antimicrob. Chemother., 2005, 56, 372-379.
106. Zhang, X.; Neamati, N.; Lee, Y.K.; Orr, A.; Brown, R.D.; Whitaker, N.; Pommier, Y.; Burke, T.R.Jr. Arylisothiocyanate- Containing Esters of Caffeic Acid Designed as Affinity Ligands for HIV-1 Integrase. Bioorg. Med. Chem., 2001, 9, 1649-1657
107. Mahmood, N.; Moore, P.S.; De Tommasi, N.; De Simone, F.; Hay, A.J.; Pizza, C. Inhibition of HIV infection by caffeolyquinic acid derivatives. Antiviral Chem. Chemother., 1993, 4, 235-240.
108. Robinson, W.E.; Reinecke, M.G.; AbdelMalek, S.; Jia, Q.; Chow, S. A. Inhibitors of HIV-1 replication that inhibit HIV integrase. Proc. Natl. Acad. Sci. USA, 1996, 93, 6326-6331.
109. Neamati, N.; Hong, H.X.; Sunder, S.; Milne, G.W.A.; Pommier, Y. Potent inhibitors of human immunodeficiency virus type 1 integrase: Identification of a novel four-point pharmacophore and tetracyclines as novel inhibitors. Mol. Pharmacol., 1997, 52, 1041-1055.
110. Neamati, N.; Hong, H.X.; Mazumder, A.; Wang, S.M.; Sunder, S.; Nicklaus, M.C.; Milne, G.W.A.; Proksa, B.; Pommier, Y. Depsides and depsidones as inhibitors of HIV-1 integrase: Discovery of novel inhibitors through 3D database searching. J. Med. Chem., 1997, 40, 942-951.
111. McDougall, B.; King, P.J.; Wu, B.W.; Hostomsky, Z.; Reinecke, M.G.; Robinson, W.E. Dicaffeoylquinic and dicaffeoyltartaric acids are selective inhibitors of human immunodeficiency virus type 1 integrase. Antimicrob. Agents Chemother., 1998, 42, 140-146.
112. Robinson, W.E.; Cordeiro, M.; AbdelMalek, S.; Jia, Q.; Chow, S.A.; Reinecke, M.G.; Mitchell, W.M. Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: Inhibition of the core catalytic domain of human immunodeficiency virus integrase. Mol. Pharmacol., 1996, 50, 846-855.
113. Lin, Z.; Neamati, N.; Zhao, H.; Kiryu, Y.; Turpin, J.A.; Aberham, C.; Strebel, K.; Kohn, K.; Witvrouw, M.; Pannecouque, C.; Debyser, Z.; De Clercq, E; Rice, W.G.; Pommier, Y.; Burke, T.R.Jr. Chicoric Acid Analogues as HIV-1 Integrase Inhibitors. J. Med. Chem., 1999, 42, 1401-1414.
114. King, P.J.; Ma, G.; Miao, W.; Jia, Q.; McDougall, B.R.; Reinecke, M.G.; Cornell, C.; Kuan, J.; Kim, T.R.; Robinson, W.E.Jr. Structure- Activity Relationships: Analogues of the Dicaffeoylquinic and Dicaffeoyltartaric Acids as Potent Inhibitors of Human Immunodeficiency Virus Type 1 Integrase and Replication. J. Med. Chem., 1999, 42, 497-509.
115. Reinke, R.A.; King, P.J.; Victoria, J.G.; McDougall, B.R.; Ma, G.; Mao, Y.; Reinecke, M.G.; Robinson, W.E.Jr. Dicaffeoyltartaric Acid Analogues Inhibit Human Immunodeficiency Virus Type 1 (HIV-1) Integrase and HIV-1 Replication at Nontoxic Concentrations. J. Med. Chem., 2002, 45, 3669-3683.
116. Hwang, D.J.; Kim, S.N.; Choib, J.H.; Leea, Y.S. Dicaffeoyl- or Digalloyl Pyrrolidine and Furan Derivatives as HIV Integrase Inhibitors. Bioorg. Med. Che., 2001, 9, 1429-1437.
117. Lee, S.U.; Shin, C.G.; Lee, C.K.; Lee, Y.S. Caffeoylglycolic and caffeoylamino acid derivatives, halfmers of L-chicoric acid, as new HIV-1 integrase inhibitors. Eur. J. Med. Chem., 2007, 42, 1309-1315.
118. Xu, Y.W.; Zhao, G.S.; Shin, C.G., Zang, H.C.; Leec, C.K.; Leed, Y.S. Caffeoyl Naphthalenesulfonamide Derivatives as HIV Integrase Inhibitors. Bioorg. Med. Chem., 2003, 11, 3589-3593.